进展性IgA肾病与低循环MASP-3及肾小球FHR5沉积增加相关
该研究在IgA肾病患者中检测了11种血浆凝集素途径成分,发现MASP-3水平降低而其他成分升高。进展性疾病与低血浆MASP-3及肾小球C3b/iC3b/C3c、C3d、C4d、C5b-9和FHR5染色增加相关,肾小球FHR5沉积与C3b/iC3b/C3c、C3d和C5b-9沉积正相关,但与C4d无关。进展性疾病中肾小球因子H沉积减少,提示FHR5可能通过 deregulating fH 参与肾损伤。
要点
- 血浆MASP-3降低与IgA肾病进展相关,可能作为疾病严重程度的生物标志物。
- 肾小球FHR5沉积增加提示替代补体途径激活,并可作为疾病严重程度的组织标志物。
- 进展性IgA肾病中肾小球因子H沉积减少,FHR5可能通过 deregulating fH 导致肾损伤。
核心结论
- 循环MASP-3水平可作为IgA肾病疾病严重程度的生物标志物。
- 肾小球FHR5染色既可指示替代补体途径激活,也可作为疾病严重程度的组织标志物。
研究设计与样本
- 在特征明确的IgA肾病患者队列中测量了11种血浆凝集素途径成分。
主要发现
- 与健康对照相比,IgA肾病患者血浆M-ficolin、L-ficolin、MASP-1和MAp19升高,而MASP-3降低。
- 进展性疾病与低血浆MASP-3水平及肾小球C3b/iC3b/C3c、C3d、C4d、C5b-9和FHR5染色增加相关。
- 肾小球FHR5沉积与肾小球C3b/iC3b/C3c、C3d和C5b-9沉积正相关,但与肾小球C4d无关。
- 进展性疾病中肾小球因子H沉积减少。
临床怎么用
- 可考虑检测血浆MASP-3水平以评估IgA肾病疾病严重程度。
- 肾小球FHR5染色可能有助于判断替代补体途径激活和疾病严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: IgA nephropathy (IgAN) is characterized by glomerular deposition of galactose-deficient IgA1 and complement proteins and leads to renal impairment. Complement deposition through the alternative and lectin activation pathways is associated with renal injury. METHODS: To elucidate the contribution of the lectin pathway to IgAN, we measured the 11 plasma lectin pathway components in a well-characterized cohort of patients with IgAN. RESULTS: M-ficolin, L-ficolin, mannan-binding lectin (MBL)-associated serine protease (MASP)-1 and MBL-associated protein (MAp) 19 were increased, whereas plasma MASP-3 levels were decreased in patients with IgAN compared with healthy controls. Progressive disease was associated with low plasma MASP-3 levels and increased glomerular staining for C3b/iC3b/C3c, C3d, C4d, C5b-9, and factor H-related protein 5 (FHR5). Glomerular FHR5 deposition positively correlated with glomerular C3b/iC3b/C3c, C3d, and C5b-9 deposition, but not with glomerular C4d. These observations, together with the finding that glomerular factor H (fH) deposition was reduced in progressive disease, are consistent with a role for fH deregulation by FHR5 in renal injury in IgAN. CONCLUSION: Our data indicate that circulating MASP-3 levels could be used as a biomarker of disease severity in IgAN and that glomerular staining for FHR5 could both indicate alternative complement pathway activation and be a tissue marker of disease severity.
引用
- Medjeral-Thomas NR, Troldborg A, Constantinou N, et al. Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin-Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H-Related Protein-5 (FHR5) Deposition. Kidney Int Rep. 2017. PMID: 29725647. doi:10.1016/j.ekir.2017.11.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。